Med Tech-related technology assessments and clinical guidelines from NICE in February 2024

The National Institute for Health and Care Excellence (NICE) develops Interventional Procedures Guidance (IPG) for most novel interventional procedures entering the English market. The program focuses solely on clinical evidence. Recommendations may vary from "for research only" to "for use with standard arrangements for clinical governance, consent, and audit." Recommendations are not binding, although they are followed by providers and commissioners.

In February 2024, NICE published one new IPG on endoscopic sleeve gastroplasty, which recommended its use as an option to treat obesity in adults with standard arrangements for clinical governance, consent, and audit.

Health Technology Evaluations (HTE) are the new type of NICE guidance that uses the Early Value Assessment (EVA) approach to provide rapid conditional recommendations on promising health technologies that have the potential to address unmet national needs. NICE evaluates the available evidence to determine if earlier patient and system access in the NHS is appropriate while further evidence is generated.

In February 2024, NICE updated one HTE on Digitally enabled therapies for adults with depression. The technology Beating the Blues has been removed from recommendations because it is no longer available to the NHS.

One clinical guideline was updated on tuberculosis. However, no Med Tech-related changes were made.

See the full details here.

This news is just one of about 300 market access news collected by our team in the premium subscription service Market Access Monitor every week from more than 80 organizations. Access our paid service to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Access is organized as an online Database and email alert formats. Contact us to get a free, three-month, no-obligation trial.